2024 (The 7th) Toxicity Testing Alternatives and Translational Toxicology International Conference was successfully held in Nanchang

From July 3 to 6, 2024, the Committee of Toxicological Alternative and Translational Toxicology, Chinese Society of Toxicology (CSOT), in collaboration with Committee of Toxicity Testing and Alternatives, Chinese Environmental Mutagen Society (CEMS), successfully held 2024 (The 7^th) Toxicity Testing Alternatives and Translational Toxicology International Conference in Nanchang, Jiangxi.

This conference brought together more than 400 representatives, including top experts and scholars from relevant fields both domestically and internationally, as well as outstanding peers and young students.  The conference was chaired by Dr. Shuangqing Peng, Director of Committee of Toxicological Alternative and Translational Toxicology, Chinese Society of Toxicology (CSOT), Director of Committee of Toxicity Testing and Alternatives, Chinese Environmental Mutagen Society (CEMS). The opening ceremony was hosted by Professor Xingfen Yang from Southern Medical University. Opening speeches were delivered by Dr. Shuangqing Peng, Dr. Chao Liu, Vice President of the Chinese Society of Toxicology, and Professor Weidong Hao, Secretary-General of the Chinese Environmental Mutagen Society.

The conference included keynote speeches, special topic reports in sub-forums, roundtable discussions, continuing education training, and poster presentations. Representatives from China and overseas engaged in extensive discussions and exchanges on topics such as the establishment and development of alternative methods, new techniques in toxicity testing, mechanisms of translational toxicology, and the application of alternative methods.  The conference featured 59 keynote and special topic presentations, showcased 76 posters, and included over 170 academic paper abstracts.

The conference invited 17 senior experts from both domestic and international spheres to deliver keynote presentations, facilitating in-depth discussions and exchanges on hot topics related to alternative methods for toxicity testing and translational toxicology.  Keynote presentations were given by renowned experts from both China and overseas, including, Dr. Bo Li, Chinese Academy of Food and Drug Control; Dr. Lu Qiu, Shanghai Customs Technology Center; Professor Jingbo Pi, China Medical University; Professor Hui Wang, Wuhan University; Dr. Xiancheng Zeng, Shanghai Medicilon Inc.; Dr. Jianhua Qin, Dalian Institute of Chemical Physics, Chinese Academy of Sciences; Professor Dianke Yu, Qingdao University; Professor Ivan Rusyn, Texas A&M University, USA; Dr. Jin Li, Unilever Safety and Environmental Assurance Centre; Professor Yasuyuki Sakai, University of Tokyo, Japan; Dr. Nathalie Alepee, L'Oréal Research & Innovation; Professor Qiang Zhang, Emory University, USA; Dr. Christian Pellevoisin, Shanghai Xizhi Biotechnology Co., Ltd.; Dr. Chantal Smulders, Shell China; Dr. Donna Macmillan, International Cooperation on Cosmetic Safety; Professor Kan Shao, Indiana University, USA; Professor Takeshi Hori, Tokyo Medical and Dental University, Japan.  

These presentations provided in-depth discussions on Next Generation Risk Assessment (NGRA) strategies, Integrated Approaches to Testing and Assessment (IATA), and New Approach Methodologies (NAMs). They also explored the significance of mechanistic research evidence in toxicity risk assessment, new methods for predicting chemical toxicity based on toxicity pathways, the establishment of human Adverse Outcome Pathway (AOP) models and in vitro-in vivo extrapolation, new techniques for dose-response modeling, the development of cosmetic technical regulations, management strategies for new approach methods in chemical risk assessment, and the application of human induced pluripotent stem cells, organoids, and organ-on-a-chip in safety assessment decision-making, as well as the construction of microphysiological systems.